Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-17-005856
Filing Date
2017-04-03
Accepted
2017-03-31 17:32:47
Documents
90
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K insy-10k_20161231.htm 10-K 4639881
2 EX-10.17 insy-ex1017_896.htm EX-10.17 63852
3 EX-21.1 insy-ex211_12.htm EX-21.1 5372
4 EX-23.1 insy-ex231_11.htm EX-23.1 2734
5 EX-31.1 insy-ex311_10.htm EX-31.1 18019
6 EX-31.2 insy-ex312_9.htm EX-31.2 18012
7 EX-32 insy-ex32_8.htm EX-32 8023
8 GRAPHIC g2017033121273261756436.jpg GRAPHIC 18936
9 GRAPHIC g2017033121272144056435.jpg GRAPHIC 10609
  Complete submission text file 0001564590-17-005856.txt   17997397

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT insy-20161231.xml EX-101.INS 5273109
11 XBRL TAXONOMY EXTENSION SCHEMA insy-20161231.xsd EX-101.SCH 60702
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE insy-20161231_cal.xml EX-101.CAL 75302
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE insy-20161231_def.xml EX-101.DEF 199177
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE insy-20161231_lab.xml EX-101.LAB 509107
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE insy-20161231_pre.xml EX-101.PRE 413036
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35902 | Film No.: 17731583
SIC: 2834 Pharmaceutical Preparations